Copertina

Detection of Outlying Correlation Coefficients in Multicenter Clinical Trials

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lieven Desmet, David Venet, Laura Trotta, Tomasz Burzykowski, Marc Buyse
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pharmaceutical Statistics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long‐term endpoint: The non‐Gaussian case
di: Leandro Garcia Barrado, et al.
Pubblicazione: (2024)

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
di: Konstantinos Sechidis, et al.
Pubblicazione: (2024)

Principles for Defining Estimands in Clinical Trials—A Proposal
di: Tobias Mütze, et al.
Pubblicazione: (2024)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
di: Zhiwei Zhang, et al.
Pubblicazione: (2025)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
di: Anders Granholm, et al.
Pubblicazione: (2025)

Mediation Analysis of Path‐Specific Effects in Randomised Clinical Trials With Repeatedly Measured Mediators and Outcomes
di: Martin Linder, et al.
Pubblicazione: (2025)

Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials
di: Yueyang Han, et al.
Pubblicazione: (2025)

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment
di: Vahan Aslanyan, et al.
Pubblicazione: (2024)

Bayesian Power‐Based Sample Size Determination for Single‐Arm Clinical Trials With Time‐to‐Event Endpoints
di: Go Horiguchi, et al.
Pubblicazione: (2026)

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
di: Yingjie Qiu, et al.
Pubblicazione: (2024)

Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
di: Ping Gao, et al.
Pubblicazione: (2025)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
di: Chiara Micoli, et al.
Pubblicazione: (2025)

A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial
di: Xiaofei Liu, et al.
Pubblicazione: (2026)

Applying the Estimand Framework to Non‐Inferiority Trials
di: Helle Lynggaard, et al.
Pubblicazione: (2024)

Variable Duration Trial as an Alternative Design for Continuous Endpoints
di: Jitendra Ganju, et al.
Pubblicazione: (2024)

Potency Assay Variability Estimation in Practice
di: Hang Li, et al.
Pubblicazione: (2024)

Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study
di: Jerome Sepin, et al.
Pubblicazione: (2025)

“Within‐Trial” Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation
di: Emilie Højbjerre‐Frandsen, et al.
Pubblicazione: (2026)

An Adaptive Three‐Arm Comparative Clinical Endpoint Bioequivalence Study Design With Unblinded Sample Size Re‐Estimation and Optimized Allocation Ratio
di: David Hinds, et al.
Pubblicazione: (2024)

Sample Size Estimation for Correlated Count Data With Changes in Dispersion
di: Jintong Hou, et al.
Pubblicazione: (2025)

Correction to “Sample Size Estimation for Correlated Count Data With Changes in Dispersion”
Pubblicazione: (2025)

CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials
di: Tomoyoshi Hatayama, et al.
Pubblicazione: (2025)

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit
di: Yan Han, et al.
Pubblicazione: (2025)

Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints
di: Gina D'Angelo, et al.
Pubblicazione: (2025)

Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space
di: Yulia Dyachkova, et al.
Pubblicazione: (2024)

Informing the Borrowing Process for Dose‐Finding Trials by Estimating the Similarity Between Population‐Specific Dose‐Toxicity Curves
di: Dario Zocholl, et al.
Pubblicazione: (2025)

Approximate Bayesian Analysis for Borrowing External Controls for Randomized Controlled Trials With Dynamic Borrowing and Covariate Balancing Adjustment
di: Jixian Wang, et al.
Pubblicazione: (2025)

A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology
di: Jun Zhang, et al.
Pubblicazione: (2024)

Evaluating Safety Rules in Ongoing Dose‐Escalation Trials Using BOIN : A Comparative Analysis of Criteria and Their Impact on Dose‐Level Safety Assessments
di: Stefan Englert, et al.
Pubblicazione: (2026)

BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
di: Ryo Kitabayashi, et al.
Pubblicazione: (2025)

Why “Minimal Clinically Important Difference” for Interpreting the Magnitude of the Treatment Effect Is Not Useful
di: Jitendra Ganju
Pubblicazione: (2025)

Applying Bias Correction Methods to Build Hybrid Controls Using Real‐World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis
di: Heather J. Litman, et al.
Pubblicazione: (2025)

Getting (More Out of) Graphics—Practices and Principles of Data Visualisation. Data Science SeriesBy AntonyUnwin, Chapman & Hall/CRC, 2024. 446 pp. $ 74.99. ISBN: 978‐0‐36‐767399‐4
di: Wei Zhao
Pubblicazione: (2025)

A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non‐Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial Design
di: Qingyang Zhang, et al.
Pubblicazione: (2025)

Using Propensity Score Weighting to Enhance the Operating Characteristics of Power Prior in Leveraging External Data to Augment a Traditional Clinical Study
di: Heng Li, et al.
Pubblicazione: (2025)

A Tree‐Based Scan Statistic for Detecting Signals of Drug–Drug Interactions in Spontaneous Reporting Databases
di: Seok‐Jae Heo, et al.
Pubblicazione: (2025)

Application of hypothetical strategies in acute pain
di: Jinglin Zhong, et al.
Pubblicazione: (2024)

Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data
di: Carl‐Fredrik Burman, et al.
Pubblicazione: (2024)

Multiplicity Adjustment Methods for a Three‐Way Crossover Bioequivalence Study
di: David Hinds, et al.
Pubblicazione: (2026)

The Estimand Framework and Causal Inference: Complementary Not Competing Paradigms
di: Thomas Drury, et al.
Pubblicazione: (2025)